ReadMe vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

ReadMe

GrowthDeveloper Tools

API Documentation Platform

ReadMe is an API documentation platform with live in-browser API testing, personalized developer hubs, and usage analytics showing which endpoints developers actually call.

About

ReadMe is a San Francisco-based developer experience company founded in 2014 that builds interactive API documentation portals for software companies that want to give developers a best-in-class onboarding experience. The platform generates documentation from OpenAPI and Swagger specs and enhances it with a live API explorer that lets developers make real API calls directly from the documentation page, authenticated with their own credentials, removing the friction of switching to Postman or curl during evaluation. A standout differentiator is ReadMe's developer analytics dashboard, which shows API providers which endpoints are being called most, where developers drop off, and which documentation pages correlate with successful integrations, treating the dev portal as a product with measurable outcomes rather than a static publishing target. ReadMe also personalizes documentation experiences by injecting a developer's actual API keys and code examples into pages automatically, reducing copy-paste errors and accelerating time-to-first-call. The company raised $35M in a Series B in 2022 and serves customers including Cloudflare, Notion, and Intercom. Competitors include Stoplight, Redocly, and Mintlify, but ReadMe's analytics layer and personalization capabilities have established it as a preferred choice for developer-led growth teams that treat documentation as a revenue-driving channel.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.